The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-benzoylphenyl)acetic acid ID: ALA561718
Cas Number: 22071-22-3
PubChem CID: 30931
Product Number: D338910, Order Now?
Max Phase: Preclinical
Molecular Formula: C15H12O3
Molecular Weight: 240.26
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: 2-(3-Benzoylphenyl)Acetic Acid | 3-Benzoylphenylacetic acid|22071-22-3|2-(3-Benzoylphenyl)acetic acid|(3-Benzoylphenyl)acetic acid|Desmethyl Ketoprofen|m-Benzoylphenylacetic acid|Benzeneacetic acid, 3-benzoyl-|RU 4462|ACETIC ACID, (m-BENZOYLPHENYL)-|57OG4Q7B6Y|CHEMBL561718|MFCD00046549|19421 R.P.|3-Benzoylbenzeneacetic acid|Ketoprofen Imp. B (EP); (3-Benzoylphenyl)acetic Acid; 2-(3-Benzoylphenyl)acetic acid; RU 4462; m-Benzoylphenylacetic acid; Ketoprofen Impurity B|EINECS 244-760-3|RU-4462|BRN Show More⌵
Canonical SMILES: O=C(O)Cc1cccc(C(=O)c2ccccc2)c1
Standard InChI: InChI=1S/C15H12O3/c16-14(17)10-11-5-4-8-13(9-11)15(18)12-6-2-1-3-7-12/h1-9H,10H2,(H,16,17)
Standard InChI Key: ALDSXDRDRWDASQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
5.4792 -5.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4792 -4.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0417 -4.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0042 -4.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5625 -3.7667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9667 -5.8750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0042 -5.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0417 -4.6667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0042 -4.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5167 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9667 -4.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9667 -4.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4792 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5167 -5.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0000 -6.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5167 -6.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0375 -5.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0417 -6.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 10 1 0
4 2 2 0
5 3 1 0
6 1 2 0
7 1 1 0
8 3 2 0
9 4 1 0
10 9 1 0
11 2 1 0
12 11 2 0
13 12 1 0
14 7 1 0
15 7 2 0
16 15 1 0
17 14 2 0
18 17 1 0
16 18 2 0
13 9 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 240.26Molecular Weight (Monoisotopic): 240.0786AlogP: 2.54#Rotatable Bonds: 4Polar Surface Area: 54.37Molecular Species: ACIDHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.84CX Basic pKa: ┄CX LogP: 3.07CX LogD: -0.17Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.84Np Likeness Score: -0.30
References 1. Sablone MR, Cesta MC, Moriconi A, Aramini A, Bizzarri C, Di Giacinto C, Di Bitondo R, Gloaguen I, Aschi M, Crucianelli M, Bertini R, Allegretti M.. (2009) Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitors., 19 (15): [PMID:19560921 ] [10.1016/j.bmcl.2009.06.027 ] 2. Windsor MA, Hermanson DJ, Kingsley PJ, Xu S, Crews BC, Ho W, Keenan CM, Banerjee S, Sharkey KA, Marnett LJ.. (2012) Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes., 3 (9): [PMID:22984634 ] [10.1021/ml3001616 ]